bpc 157 liberty peptides FDA panel backs compounded BPC-157, KPV in win for RFK Jr An FDA Committee Just Voted

Product Specifications AOD 9604 peptide is a smaller, modified version of human growth hormone and originally developed as an anti-obesity drug

The peptide does not bind to growth hormone receptors in muscle tissue, does not stimulate protein synthesis or muscle hypertrophy, shows no effects on bone metabolism or growth, demonstrates no organ enlargement or proliferative effects, and avoids the connective tissue changes associated with growth hormone

The only retrospective human study included 12 patients who received intra-articular BPC-157 for chronic knee pain, of whom 7 reported symptom improvement lasting more than 6 months

Quantity: 50 Each per Box

If you are experiencing symptoms of B12 deficiency or belong to a high-risk group, consult your healthcare provider to determine if this test is right for you